A citation-based method for searching scientific literature

Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, Shawn J Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle, Heather Davidson, Kristyn Mccoy, Jonas Nance, Vanda Yazdani, Meredith S Irwin, Shengping Yang, David A Wheeler, John M Maris, Sharon J Diskin, C Patrick Reynolds. Cancer Res 2020
Times Cited: 12







List of co-cited articles
81 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A mechanistic classification of clinical phenotypes in neuroblastoma.
Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke,[...]. Science 2018
74
50

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, Katherine K Matthay, Wendy B London, Peter F Ambros, Akira Nakagawara, Frank Berthold, Gudrun Schleiermacher, Julie R Park,[...]. J Clin Oncol 2015
323
41

Neuroblastoma.
Katherine K Matthay, John M Maris, Gudrun Schleiermacher, Akira Nakagawara, Crystal L Mackall, Lisa Diller, William A Weiss. Nat Rev Dis Primers 2016
378
41

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
266
41

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Ruth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Geneviève Laureys, Josef Malis,[...]. Lancet Oncol 2017
142
33

Neuroblastoma.
John M Maris, Michael D Hogarty, Rochelle Bagatell, Susan L Cohn. Lancet 2007
25

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt, Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari,[...]. J Natl Cancer Inst 2018
29
25

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
P F Ambros, I M Ambros, G M Brodeur, M Haber, J Khan, A Nakagawara, G Schleiermacher, F Speleman, R Spitz, W B London,[...]. Br J Cancer 2009
195
25

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Scott C Bresler, Daniel A Weiser, Peter J Huwe, Jin H Park, Kateryna Krytska, Hannah Ryles, Marci Laudenslager, Eric F Rappaport, Andrew C Wood, Patrick W McGrady,[...]. Cancer Cell 2014
189
25

Identification of ALK as a major familial neuroblastoma predisposition gene.
Yaël P Mossé, Marci Laudenslager, Luca Longo, Kristina A Cole, Andrew Wood, Edward F Attiyeh, Michael J Laquaglia, Rachel Sennett, Jill E Lynch, Patrizia Perri,[...]. Nature 2008
804
25

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, Wendy B London, Susan G Kreissman, Helen X Chen, Malcolm Smith, Barry Anderson, Judith G Villablanca, Katherine K Matthay,[...]. N Engl J Med 2010
925
25

Chromosome 1p and 11q deletions and outcome in neuroblastoma.
Edward F Attiyeh, Wendy B London, Yael P Mossé, Qun Wang, Cynthia Winter, Deepa Khazi, Patrick W McGrady, Robert C Seeger, A Thomas Look, Hiroyuki Shimada,[...]. N Engl J Med 2005
349
25

Children's Oncology Group's 2013 blueprint for research: neuroblastoma.
Julie R Park, Rochelle Bagatell, Wendy B London, John M Maris, Susan L Cohn, Katherine K Mattay, Michael Hogarty. Pediatr Blood Cancer 2013
197
25

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, Wendy B London, Richard Sposto, Stephan A Grupp, Daphne A Haas-Kogan, Michael P Laquaglia, Alice L Yu, Lisa Diller,[...]. Lancet Oncol 2013
166
25

The genetic landscape of high-risk neuroblastoma.
Trevor J Pugh, Olena Morozova, Edward F Attiyeh, Shahab Asgharzadeh, Jun S Wei, Daniel Auclair, Scott L Carter, Kristian Cibulskis, Megan Hanna, Adam Kiezun,[...]. Nat Genet 2013
607
25

Molecular biology of neuroblastoma.
J M Maris, K K Matthay. J Clin Oncol 1999
479
25

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
Nai-Kong V Cheung, Jinghui Zhang, Charles Lu, Matthew Parker, Armita Bahrami, Satish K Tickoo, Adriana Heguy, Alberto S Pappo, Sara Federico, James Dalton,[...]. JAMA 2012
241
25

MYCN amplification and ATRX mutations are incompatible in neuroblastoma.
Maged Zeineldin, Sara Federico, Xiang Chen, Yiping Fan, Beisi Xu, Elizabeth Stewart, Xin Zhou, Jongrye Jeon, Lyra Griffiths, Rosa Nguyen,[...]. Nat Commun 2020
20
25

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
Julie R Park, Susan G Kreissman, Wendy B London, Arlene Naranjo, Susan Lerner Cohn, Michael D Hogarty, Sheena C Tenney, Daphne Haas-Kogan, Peter John Shaw, Jacqueline M Kraveka,[...]. JAMA 2019
62
25

Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power.
Karl-Frederick Karstens, Eugen Bellon, Adam Polonski, Gerrit Wolters-Eisfeld, Nathaniel Melling, Matthias Reeh, Jakob R Izbicki, Michael Tachezy. Oncotarget 2020
3
66

KEGG: kyoto encyclopedia of genes and genomes.
M Kanehisa, S Goto. Nucleic Acids Res 2000
16

Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity.
Pamali Fonseka, Michael Liem, Cemil Ozcitti, Christopher G Adda, Ching-Seng Ang, Suresh Mathivanan. J Extracell Vesicles 2019
32
16

Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma.
Ilhem Diboun, Lorenz Wernisch, Christine Anne Orengo, Martin Koltzenburg. BMC Genomics 2006
336
16

NCBI GEO: mining tens of millions of expression profiles--database and tools update.
Tanya Barrett, Dennis B Troup, Stephen E Wilhite, Pierre Ledoux, Dmitry Rudnev, Carlos Evangelista, Irene F Kim, Alexandra Soboleva, Maxim Tomashevsky, Ron Edgar. Nucleic Acids Res 2007
881
16


Targets and Antibody Formats for Immunotherapy of Neuroblastoma.
Jeong A Park, Nai-Kong V Cheung. J Clin Oncol 2020
14
16

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR.
F Berthold, A Faldum, A Ernst, J Boos, D Dilloo, A Eggert, M Fischer, M Frühwald, G Henze, T Klingebiel,[...]. Ann Oncol 2020
12
16

Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates.
Natalia Pstrąg, Katarzyna Ziemnicka, Hans Bluyssen, Joanna Wesoły. Mol Cancer 2018
22
16

KEGG: Kyoto Encyclopedia of Genes and Genomes.
H Ogata, S Goto, K Sato, W Fujibuchi, H Bono, M Kanehisa. Nucleic Acids Res 1999
16

Batch correction of microarray data substantially improves the identification of genes differentially expressed in rheumatoid arthritis and osteoarthritis.
Peter Kupfer, Reinhard Guthke, Dirk Pohlers, Rene Huber, Dirk Koczan, Raimund W Kinne. BMC Med Genomics 2012
29
16

Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data.
Nadezhda T Doncheva, John H Morris, Jan Gorodkin, Lars J Jensen. J Proteome Res 2019
256
16

DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis.
Brad T Sherman, Da Wei Huang, Qina Tan, Yongjian Guo, Stephan Bour, David Liu, Robert Stephens, Michael W Baseler, H Clifford Lane, Richard A Lempicki. BMC Bioinformatics 2007
344
16


limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
16

affy--analysis of Affymetrix GeneChip data at the probe level.
Laurent Gautier, Leslie Cope, Benjamin M Bolstad, Rafael A Irizarry. Bioinformatics 2004
16

Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
Bjørn Helge Haug, Øyvind H Hald, Peter Utnes, Sarah A Roth, Cecilie Løkke, Trond Flægstad, Christer Einvik. Anticancer Res 2015
29
16

The Gene Expression Omnibus Database.
Emily Clough, Tanya Barrett. Methods Mol Biol 2016
439
16

Exploration, normalization, and summaries of high density oligonucleotide array probe level data.
Rafael A Irizarry, Bridget Hobbs, Francois Collin, Yasmin D Beazer-Barclay, Kristen J Antonellis, Uwe Scherf, Terence P Speed. Biostatistics 2003
16

Evaluating oligonucleotide properties for DNA microarray probe design.
Xiao-Qin Xia, Zhenyu Jia, Steffen Porwollik, Fred Long, Claudia Hoemme, Kai Ye, Carsten Müller-Tidow, Michael McClelland, Yipeng Wang. Nucleic Acids Res 2010
9
22

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
M Ashburner, C A Ball, J A Blake, D Botstein, H Butler, J M Cherry, A P Davis, K Dolinski, S S Dwight, J T Eppig,[...]. Nat Genet 2000
16

ImaGEO: integrative gene expression meta-analysis from GEO database.
Daniel Toro-Domínguez, Jordi Martorell-Marugán, Raúl López-Domínguez, Adrián García-Moreno, Víctor González-Rumayor, Marta E Alarcón-Riquelme, Pedro Carmona-Sáez. Bioinformatics 2019
27
16

Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
Elizabeth Sokol, Ami V Desai, Mark A Applebaum, Dominique Valteau-Couanet, Julie R Park, Andrew D J Pearson, Gudrun Schleiermacher, Meredith S Irwin, Michael Hogarty, Arlene Naranjo,[...]. J Clin Oncol 2020
9
22

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.
L L Wang, R Teshiba, N Ikegaki, X X Tang, A Naranjo, W B London, M D Hogarty, J M Gastier-Foster, A T Look, J R Park,[...]. Br J Cancer 2015
67
16

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Mark Sausen, Rebecca J Leary, Siân Jones, Jian Wu, C Patrick Reynolds, Xueyuan Liu, Amanda Blackford, Giovanni Parmigiani, Luis A Diaz, Nickolas Papadopoulos,[...]. Nat Genet 2013
274
16

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
184
16

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
Tom Monclair, Garrett M Brodeur, Peter F Ambros, Hervé J Brisse, Giovanni Cecchetto, Keith Holmes, Michio Kaneko, Wendy B London, Katherine K Matthay, Jed G Nuchtern,[...]. J Clin Oncol 2009
423
16

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Yael P Mossé, Megan S Lim, Stephan D Voss, Keith Wilner, Katherine Ruffner, Julie Laliberte, Delphine Rolland, Frank M Balis, John M Maris, Brenda J Weigel,[...]. Lancet Oncol 2013
409
16

Clinical features of ATRX or DAXX mutated neuroblastoma.
Sho Kurihara, Eiso Hiyama, Yoshiyuki Onitake, Emi Yamaoka, Keiko Hiyama. J Pediatr Surg 2014
25
16

Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
Arlene Naranjo, Meredith S Irwin, Michael D Hogarty, Susan L Cohn, Julie R Park, Wendy B London. JCO Clin Cancer Inform 2018
11
18

Prognostic impact of gene expression-based classification for neuroblastoma.
André Oberthuer, Barbara Hero, Frank Berthold, Dilafruz Juraeva, Andreas Faldum, Yvonne Kahlert, Shahab Asgharzadeh, Robert Seeger, Paola Scaruffi, Gian Paolo Tonini,[...]. J Clin Oncol 2010
98
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.